-
Most Recent
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
4 Reasons to Buy Hexo Stock Despite the Rough Ride
Hexo stocks hasn't had the best luck lately, but interested investors might be wise to view this as a buying opportunity.
6 Catalysts That Say National Marijuana Legalization Is Nigh
Matt McCall walks us through the ENORMOUS implications for marijuana investors as the road to marijuana legalization gets shorter and shorter.
Canopy Growth Stock Is a Buy Near $32
While the current valuation for CGC is insane, Canopy Growth stock will grow into it with time, making it a promising long-term play.
Why It’s Not Time to Buy Hexo Stock Yet
It's unclear if Hexo stock can meet its aggressive growth plans for 2020. Meanwhile, its marketing practices are coming under scrutiny.
3 Keys to Investing in Next-Gen Healthcare Stocks
The precision medicine revolution is one of the greatest wealth building opportunities of your life. Here's why.
9 Catalysts That Will Drive Chinese Biotech Stocks Much Higher
Matt McCall is extremely bullish on China and the big opportunities in several sectors, but Chinese biotech stocks top his list.
Hexo Stock Is Almost Worth Buying Now
HEXO stock has a lot of headwinds to deal with, so you should wait for it to come in some more before nibbling at it.
These Are the 4 Reasons HEXO Stock Is Tanking Right Now
HEXO stock has taken a big hit in the past three months along with the rest of the cannabis stock group. Factors such as aggressive guidance, cannabis pricing pressures and new Canadian regulations have weighed on enthusiasm for Hexo.
Hexo Stock Has Potential, But Skip It for Now
The Canadian market has runway with edibles and beverages. But the real growth driver is the United States. Once Hexo and its competitors can expand south into America, investors will have a clearer picture of the industry's growth potential. Until then, the stock is not a buy. But long-term, HEXO stock may be a smart way to play the cannabis growth story.
3 Potential Catalysts That Could Send Tilray Shares Soaring
Despite falling from the highs, TLRY has potential. Here are three potential positive catalysts that could unlock Tilray's potential.
Cannabis Bulls Should Consider HEXO Stock … Eventually
HEXO stock is a classic falling knife right now, but could be a value play once it finds a bottom.
Hot Investing Trends Updates: IoT, EV, Streaming Video and Marijuana Legalization
From IoT to marijuana legalization, Matt McCall rounds up the latest news to help you make money in the world’s biggest investment themes.
Aurora Cannabis Stock Is the Bitcoin of Equity Markets
Aurora Cannabis has a large addressable market globally. However, inventory build-up is a near-term concern, and growth in the medicinal segment needs to be watched.
Marijuana Stocks: How to Start Investing in Pot’s Explosive Growth
Legal marijuana is slated to skyrocket from less than $10 billion today, into a $100 BILLION juggernaut -- making marijuana stocks the biggest investment opportunity over the next few years.
Aurora Cannabis Stock Has a Cash Burn Problem
ACB stock has come down to earth now that analysts are taking a closer look at the company's balance sheet. If Nelson Peltz doesn't find Aurora a partner soon, Aurora stock may find itself in a capital crunch.
$30 Is Still a Possibility for Canopy Growth Stock
The price of CGC stock may soon drop to $30. There isn't much support around the levels where it is currenly trading.
